Home Healthcare Medical Devices Latin America Diabetes Devices Market

Latin America Diabetes Devices Market Size, Share & Trends Analysis Report By Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By Application (Hospitals, Homecare, Diagnostics Centers) and By Country (Brazil, Mexico, Argentina, Chile, Colombia, Rest of LATAM) Forecasts, 2026-2034

Last Updated: September 18, 2026 | Author: Debashree Bora | Format:

Market Overview

The Latin America diabetes devices market size was valued at USD 1.95 billion in 2025 and is projected to grow from USD 2.08 billion in 2026 to  USD 3.48 billion by 2034 at a CAGR of 6.64% during the forecast period 2026-2034.

Diabetes is a condition in which the pancreas is unable to produce insulin. Untreated diabetes is characterized by increased blood sugar levels. Diabetes medications are used, in particular, for diabetes diagnosis. The goal of diabetes treatment is to increase glucose levels in the body. Diabetes care gadgets are used to keep track of a diabetic's blood glucose levels. A continuous glucose monitor (CGM) is a medical gadget that continuously tracks and monitors a diabetic patient's blood glucose levels throughout the day. People with diabetes will benefit from this wearable device since it can help them manage their glucose levels. Ketone monitors, blood glucose monitors, continuous glucose monitors, insulin pumps, smart insulin pens, and diabetes management applications are all examples of diabetic monitoring devices. Glucose monitoring devices aid in the maintenance and control of glucose levels, hence enhancing the patient's health.

Diabetic prevalence is significant in Latin American countries, and Mexico is noted for having a large number of diabetic patients due to the country's growing incidence of Type-2 diabetes. Type-2 diabetes affects the majority of diabetic patients in Latin America, accounting for about 90% of the total diabetic population.

Latin America Diabetes Devices Market Size

Download a Free Sample To learn more about this report.

Segmental Analysis

The Latin America Diabetes Devices Market region segment has been categorized by kind, distribution channel, and application.

According to type, the diabetes devices market is divided into blood glucose monitoring devices and insulin administration devices. The insulin delivery devices sector is likely to lead the market, with a projected value of USD 30,412.19 million by 2030, representing a 7.62% CAGR over the forecast period.

The expanding number of rules and approvals for technological developments in insulin delivery devices such as insulin pens, insulin pumps, jet injectors, and other devices are some of the key driving factors for demand for insulin delivery devices. The growing acceptability of insulin patches and smart insulin pumps for diabetes self-management is one of the factors boosting demand for insulin delivery devices.

Based on the distribution channel, the diabetic devices market has been divided into hospitals, retail pharmacies, diabetes clinics/centres, internet pharmacies, and others. The retail pharmacies sector is estimated to lead the market, with revenues of USD 11,491.59 million by 2030, representing a CAGR of 6.92% over the forecast period. Some of the reasons projected to promote the growth of the retail sales segment over the projection period include the rising penetration of private-label products in retail stores at lower prices.

Latin America Diabetes Devices Market Size By Segments

Request Customizationto receive a tailored report.

Based on application, the diabetic devices market has been divided into hospitals, home care, and diagnostic centres. The hospital's category is likely to lead the market, with revenues of USD 19,845.68 million expected by 2030, representing a CAGR of 6.42% during the forecast period. Diabetic people are increasingly being admitted to hospitals.

Type 1 diabetes patients had longer hospital stays, a higher death rate, and more complications than type 2 diabetes patients. Type 1 diabetes patients are administered insulin to prevent ketoacidosis, although they have a higher rate of hyperglycemia. As a result, an increase in the number of type 1 diabetes patients in hospitals, as well as an increase in the demand for continuous blood glucose monitoring, are two factors pushing up the demand.

Latin America Diabetes Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Latin America Diabetes Devices Market is predicted to grow at a CAGR of 6.64% over the forecast period, reaching a total value of  USD 3.48 billion in 2034. The prevalence of diabetes is high in Latin American countries, and Mexico is known for having a big number of diabetic patients due to the country's rising Type-2 diabetes rate. In Latin America, type-2 diabetes affects the vast majority of diabetic individuals, accounting for over 90% of the total diabetic population.

Healthcare reforms can be achieved through effective initiatives for universal coverage, changes in the care model, and increased resources directed to the detection and prevention of chronic illness. This will make it easier for patients in this region to obtain medical devices. In order for the product to be offered in the market, organizations participating in the manufacturing of Diabetes Care Devices also need to ensure that the technology used in the device is feasible. Companies in the Latin American market have a lot of potential with unique designs and practical products. Insulin cartridges and insulin pens have the largest market shares in Brazil's insulin delivery devices market. The rising demand for insulin has prompted extensive research and development into the production of various painless insulin delivery systems, such as CGMs. Syringes were the sole way to deliver insulin at first, but they were unpleasant and inconvenient to use. Brazil has a large number of diabetes patients, which propels the device industry forward. The insulin delivery device market in Brazil accounts for 54% of the total device market. The Latin American market will be of more interest in the near future since it is still developing and is likely to dominate the industry in the future because of the vast patient pool in this region.

In Argentina, it is observed that obesity in the public has increased which is the reason for the increased number of diabetic patients in the country and the growth is expected to be even more in the future and hence the demand for diabetic care devices is also expected to accelerate.

List of Key and Emerging Players in Latin America Diabetes Devices Market

Roche Diagnostics
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Terumo
Tandem

Key Industry Developments

June 2026
Abbott expanded its diabetes care ecosystem by extending its strategic collaboration with Medtronic to commercialize dual glucose-ketone sensing technology integrated with MiniMed automated insulin delivery systems. The partnership strengthens next-generation diabetes device offerings that are expected to benefit markets across Latin America.
June 2025
Tandem Diabetes Care entered a strategic partnership with Abbott to integrate Abbott's under-development dual glucose-ketone sensor with Tandem's insulin delivery systems, expanding connected diabetes management solutions and enhancing interoperability between continuous glucose monitoring and insulin pump technologies.

Report Scope

Segmentation

By Type 2
  • Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
By Distribution Channel 5
  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others
By Application 3
  • Hospitals
  • Homecare
  • Diagnostics Centers
Competitive Coverage Roche Diagnostics · Johnson & Johnson · Abbott Laboratories · Novo Nordisk · Terumo
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Latin America diabetes devices market was valued at USD 3.48 billion in 2026.

Increased investment in R and D is the key driver for the growth of the Latin America diabetes devices market.

Insulin delivery devices market sector is expected to dominate over the forecast period.

The key players in the Latin America diabetes devices market include Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Terumo, Tandem.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: